retraction · European Journal of Pharmacology

Retraction notice to “Candesartan and glycyrrhizin ameliorate ischemic brain damage through downregulation of the TLR signaling cascade" [Eur. J. Pharmacol 724 (2014) 43–50]

2024Open accessZagazig University

In plain language

No abstract is available for this record, so no summary has been generated.

Research topics

Pharmacological Effects of Natural Compounds
Neurological Disease Mechanisms and Treatments

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

View on publisher site Record on OpenAlex

DOI: 10.1016/j.ejphar.2024.177018

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.

New to MARATTO™? Create a free account.